30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Landsittel Michael

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 45% 68% 82%
Transactions
9 0% Buy
34 71% Buy
47 69% Buy
Landsittel Michael's trades of Blueprint Medicines Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-03-07 2025-03-05 S Sale
48,211 +27.2%
488.77
US$1,486,343
48,211 +27.2% 488.77 US$1,486,343
2024-08-19 2024-08-15 PlS Planned sale
19,052 -1.5%
197.84
US$4,697,480
19,052 -1.5% 197.84 US$4,697,480
2024-08-15 2024-08-15 PrS Proposed sale
71,260
67.32
US$1,972,656
71,260 67.32 US$1,972,656
2024-05-17 2024-05-15 PlS Planned sale
1,364 -1.9%
106.56
US$145,348
1,364 -1.9% 106.56 US$145,348
2024-05-17 2024-05-15 PlS Planned sale
2,486 -3.3%
107.17
US$266,425
2,486 -3.3% 107.17 US$266,425
2024-05-15 2024-05-15 PrS Proposed sale
3,850
106.96
US$411,784
3,850 106.96 US$411,784
2024-05-06 2024-05-02 PlS Planned sale
10,000 -17.5%
105.00
US$1,050,000
10,000 -17.5% 105.00 US$1,050,000
2024-05-02 2024-05-02 PrS Proposed sale
10,000
105.00
US$1,050,000
10,000 105.00 US$1,050,000
2024-04-01 2024-03-28 PlS Planned sale
5,000 -9.6%
95.00
US$475,000
5,000 -9.6% 95.00 US$475,000
2024-03-28 2024-03-28 PrS Proposed sale
5,000
95.00
US$475,000
5,000 95.00 US$475,000
2024-03-19 2024-03-15 PlS Planned sale
2,467 -5.0%
88.94
US$219,415
2,467 -5.0% 88.94 US$219,415
2024-03-19 2024-03-15 PlS Planned sale
1,638 -3.2%
88.08
US$144,275
1,638 -3.2% 88.08 US$144,275
2024-03-19 2024-03-15 PlS Planned sale
4,629 -8.3%
87.09
US$403,140
4,629 -8.3% 87.09 US$403,140
2024-03-19 2024-03-15 PlS Planned sale
912 -1.6%
88.88
US$81,059
912 -1.6% 88.88 US$81,059
2024-03-19 2024-03-15 PlS Planned sale
1,413 -2.4%
88.27
US$124,726
1,413 -2.4% 88.27 US$124,726
2024-03-19 2024-03-15 PlS Planned sale
2,675 -4.4%
87.10
US$232,992
2,675 -4.4% 87.10 US$232,992
2024-03-15 2024-03-15 PrS Proposed sale
13,734
87.78
US$1,205,622
13,734 87.78 US$1,205,622
2024-03-11 2024-03-07 S Sale
5,003 -8.2%
90.69
US$453,722
5,003 -8.2% 90.69 US$453,722
2023-03-08 2023-03-06 S Sale
96 -0.2%
44.48
US$4,270
96 -0.2% 44.48 US$4,270
2023-03-08 2023-03-06 S Sale
2,911 -5.6%
45.72
US$133,091
2,911 -5.6% 45.72 US$133,091
2022-03-08 2022-03-07 S Sale
1,047 -2.6%
56.19
US$58,831
1,047 -2.6% 56.19 US$58,831
2022-03-08 2022-03-03 S Sale
1,328 -3.2%
60.27
US$80,039
1,328 -3.2% 60.27 US$80,039
2021-03-05 2021-03-04 S Sale
1,411 -4.7%
86.61
US$122,207
1,411 -4.7% 86.61 US$122,207
2021-03-05 2021-03-04 S Sale
96 -0.3%
88.98
US$8,542
96 -0.3% 88.98 US$8,542
2020-03-11 2020-03-09 S Sale
400 -2.3%
51.97
US$20,788
400 -2.3% 51.97 US$20,788